| Client: | Mid-sized global pharmaceutical company |
| Challenge: | Help a pharmaceutical company with no experience in biotechnology products to revise its manufacturing and regulatory processes. |
| Outcome: | PharmaNet Consulting experts in Chemistry/Manufacturing/Controls and Regulatory Affairs suggested process modifications that enabled the client to meet the requirements for a Biological Investigational New Drug. The biological recently completed initial Phase I studies. |













504 Carnegie Center, Princeton, NJ 08540